Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-Cyclin-dependent Kinase (CDK)-LCI133
LCI133

Chemical Structure : LCI133

CAS No.: 3065284-87-6

LCI133 (LCI-133)

Catalog No.: PC-25672Not For Human Use, Lab Use Only.

LCI133 is a highly potent, selective multikinase CDK4/6/9 and AURKA/B inhibitor with IC50 of 4.7/10.2/4.1 nM for CDK4/6/9 and 2.8/10.6 nM for AURKA/B.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    LCI133 is a highly potent, selective multikinase CDK4/6/9 and AURKA/B inhibitor with IC50 of 4.7/10.2/4.1 nM for CDK4/6/9 and 2.8/10.6 nM for AURKA/B.
    LCI133 shows minimal inhibition of PI3Kδ with IC50 of 897 nM, has littile to no activity against CDK2/cyclin E, CDK7/cyclin H and DNA-PK.
    LCI133 is cytotoxic to multiple cancer cell lines, arrests the cell cycle, and induces apoptosis.
    LCI133 has IC50 of 0.17, 0.21, 0.19, 0.34, and 0.55 μM, in human MYCN-amplified and nonamplified NB cell lines (BE(2)-C, NGP, Kelly, SK-N-AS, and SHEP, respectively), also exhibits submicromolar activity in MCL (Jeko-1 and Mino), prostate cancer (22Rv1), and endometrial cancer (AN3 CA) cellular models.
    LCI133 blocks CDK9 signaling axis and suppresses MYCN and MCL-1 transcription in MYCN-amplified neuroblastoma (NB).
    LCI133 (40 mg/kg/day, i.p.) significantly reduces the growth of BE(2)-C xenografted tumors without notable change in behavior or mouse body weight.

    Physicochemical Properties

    M.Wt 578.67
    Formula C33H34N6O4
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    7-Cyclopentyl-N,N-dimethyl-2-((4-(2-morpholino-4-oxo-4H-chromen-7-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide

    References

    1. Maddeboina K, et al. J Med Chem. 2025 Nov 6. doi: 10.1021/acs.jmedchem.5c01688.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: